Session

Overview: This joint ESTRO-EORTC symposium will focus on new approaches to characterize and treat oligometastatic disease (OMD) with radiotherapy (RT). First, the heterogeneity within the metastatic state will be described, followed by an illustration of the value of local consolidative therapies (LCT) and metastasis-directed therapies (MDT). Furthermore, benefits and limitations of RT as LCT / MDT will be described. In addition, OligoCare as a new model will be introduced and a report of the first six months of OligoCare will be given. Challenges of RT planning for OMD will be discussed in addition to image guidance strategies. Finally, the importance of modern imaging techniques for lesion detection, treatment planning and response assessment as well as the key role of imaging to design future trials will be discussed.